Following the audit carried out by Bureau Veritas Certification, SATT AxLR * this year obtained its ISO 9001: 2015 certification relating to quality management for all of its activities for promoting inventions resulting from public research.
The ISO 9001: 2015 certification obtained with mastery by SATT AxLR covers the widest scope of its activity. These include the protection, maturation, transfer of technologies, knowledge and results of research programs from shareholders ** and partner institutions *** of SATT AxLR to companies of all sizes and in particular through the creation of start-ups. In addition to this series of missions, which are now certified, there is the provision of research and development consulting services.
This first certification crowns the intense work carried out by all employees and also marks the commitment of SATT AxLR to a continuous improvement process.
Very involved in obtaining certification, Philippe Nérin, President of SATT AxLR underlines: "As part of our certification process, the investment of all SATT AxLR teams has been remarkable. This certification rewards the solidity and rigor of the management of our processes. We are aware of the importance of quality in our efforts. It was essential for us to put in place a quality management system allowing us to constantly improve our services and strengthen our good practices for the benefit of our entire ecosystem. Our ambition is to develop high-level services in line with the needs of our customers and our shareholders ”.
Bureau Veritas is the world leader in laboratory testing, inspections and certification services.

* The SATT (Société d'Acceleration de Transfert de Technologies) AxLR is one of the 13 companies operating on the national territory whose activity concerns economic development in the high technology sector from the scientific production of public research . Find out more: axlr.com
** Shareholders: CNRS, Université Montpellier, IRD, Inserm, Université Via Domitia, Sup Agro, Inrae, Université Nîmes
*** Partners: Cirad, IMT Mines Alès, CHU Montpellier, CHU Nîmes